➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
Medtronic
McKinsey
McKesson
Harvard Business School
Baxter

Last Updated: August 7, 2020

DrugPatentWatch Database Preview

Litigation Details for AbbVie Inc. v. Cipla Limited (D. Del. 2017)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in AbbVie Inc. v. Cipla Limited
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for AbbVie Inc. v. Cipla Limited (D. Del. 2017)

Date Filed Document No. Description Snippet Link To Document
2017-11-10 1 United States Patent No. 7,148,359 C1 (together “the ’359 Patent”); (2) United States Patent Number 7,364,752… civil action for patent infringement of: (1) United States Patent Number 7,148,359 B2 as amended by …1272nd), which amended the ’359 Patent as United States Patent No. 7,148,359 C1. AbbVie is the owner by … & 100mg/ 25mg With Respect to U.S. Patent Nos. 7,148,359; 6,364,752; 8,025,899; 8,268,349; 8,309,613…United States Patent No. 7,364,752 C1 (together “the ’752 Patent”); (3) United States Patent Number 8,025,899 External link to document
0000-00-00 12 Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,148,359; 7,364,752; 8,025,899; 8,268,349…2017 5 April 2018 1:17-cv-01631 835 Patent - Abbreviated New Drug Application(ANDA) External link to document
2017-11-10 4 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,148,359; 7,364,752; 8,025,899…10 November 2017 1:17-cv-01631 835 Patent - Abbreviated New Drug Application(ANDA) External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Baxter
Harvard Business School
Johnson and Johnson
Merck
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.